Evidence map›Paper›PMID 29731687›Full record

ArticleCentral-European journal of immunology2018

The effect of mast cells on the biological characteristics of prostate cancer cells.

Zhifang Ma, Liang Yue, Zhaoliang Xu, Sheng Zeng, Yukun Ma, Zhuoping Li, Wei Li, Dongwen Wang

Open access · goldAbstract read
In one paragraph

Article in Central-European journal of immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Human Group IIA Secreted Phospholipase AInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhifang MaDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Liang YueDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Zhaoliang XuDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Sheng ZengDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Yukun MaDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Zhuoping LiDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Wei LiDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
Dongwen WangDepartment of Urology, First Hospital of Shanxi Medical University, Taiyuan, China.
First Hospital of Shanxi Medical University · CNShanxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aim of the studyTo investigate the effects of mast cells on the proliferation, invasion, and metastasis of prostate cancer cells. MATERIAL AND

methodsThe mast cell P815 and prostate cancer LNCaP cells were chosen using a Transwell chamber to construct a two-cell cocultured in vitro model to observe the migration of mast cells to prostate cancer cells.

resultsIn the migration experiment, the migration rate of mast cells from the experimental group (%) was 10.167

conclusionsMast cells could promote the proliferation of prostate cancer cells and the occurrence of epithelial mesenchymal transition (EMT), which could promote the invasion and metastasis of prostate cancer cells.

Indexed as

C-kit inhibitorepithelial mesenchymal transitionmast cellsprostate cancer cellsSCF/c-kit pathway

Identifiers

PMID29731687
PMCPMC5927167
OpenAlexW2802903605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.